SMSbiotech is a California-based biotech company that was founded by Dr. Abdulkader Rahmo, Tom Pistone, Mohamed Diab, Amy Mousavi, and Firas Abras in 2015. Through a combination of hard work and over 30 years of experience in research and applications, we have been able to introduce a new proprietary technology that will change the way the life science industry approaches the research of cells, drugs and toxins. Based on our patented, revolutionary, adult stem cell research technologies, new potential treatments can be tested earlier than with traditional methods, and in a cost-effective way.
The SMSbiotech platform technology will penetrate the regenerative medicine and bio-manufacturing markets and lay the groundwork for developing alternative, more efficient, and relevant treatments and medications.
We believe that we are only as strong as our team. We strive to hire and consult with people who share our vision and dedication.
Co-Founder, Interim CEO, CSO
Bachelor in Biochemistry from the Swiss Federal Institute of Technology; PhD in Biochemistry and Molecular Biology from the University of Southern California. Associate professor. Over 30 years of experience in research and applications, of which 8 years have been dedicated to his current research. Co-founded several entities, including the National Commission for Biotechnology.
Board of Directors
Board of Advisers
Financial expert with over 20 years of experience as a CFO and a CPA, business owner; highly experienced in both established and startup companies.
Former associate professor at MIT (9 years), founder and former director of the Adult Stem Cell Technology Center at the Boston Biomedical Research Institute (5 years), currently founder and Director of Asymmetrex, LLC.
Senior Scientist at the Jet Propulsion Laboratory (8 years), world expert in industrial digital communication; experienced in medical device engineering, graduate level lecturer at UCI.